V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)活性蛋白
Active V-Myc Myelocytomatosis Viral Oncogene Homolog (MYC)
C-Myc; BHLHE39; Myc Proto-Oncogene Protein; VMyc Class E basic helix-loop-helix protein 39; Transcription factor p64; Proto-oncogene c-Myc
- 編號APB290Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點6.6
- 應用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1920 ¥ 4800 ¥ 9600 ¥ 28800 ¥ 72000
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
活性實驗
MYC (Myc proto-oncogene protein) is a nuclear phosphoprotein that binds specific sequence of DNA. MYC functions as a transcription factor and regulates transcription of target genes. It has been proven that c-Myc protein is intracellularly associated with TBP (TATA-binding protein) of the TFIID transcription initiation complex; besides, TRRAP (Transformation/transcription domain-associated protein) is thought to be an essential cofactor for the MYC. Thus a binding ELISA assay was conducted to detect the interaction of MYC with TBP and TRRAP. Briefly, recombinant human MYC were diluted serially in PBS, with 0.01%BSA (pH 7.4). Duplicate samples of 100uL were then transferred to TBP-coated and TRRAP microtiter wells and incubated for 2h at 37°C. Wells were washed with PBST and incubated for 1h with anti-MYC pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37°C. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of MYC with TBP and TRRAP was shown in Figure 1 and Figure 2 separately, and this effect was in a dose dependent manner.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
增值服務
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB290Hu01 | V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB290Hu01 | V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)活性蛋白 | Cell?culture;?Activity?Assays. |
RPB290Hu02 | V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB290Hu02 | V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)多克隆抗體 | WB; IHC; ICC; IP. |
PAB290Hu01 | V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)多克隆抗體 | WB |
LAB290Hu81 | V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
LAB290Hu71 | V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)多克隆抗體(生物素標記) | WB; IHC; ICC. |
MAB290Hu22 | V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)單克隆抗體 | WB; IHC; ICC; IP. |
SEB290Hu | V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB290Hu | V-Myc骨髓細胞瘤病毒癌基因同源物(MYC)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |